Safe the date international workshop on Management of Peritoneal Surface Malignancy
The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as a treatment for peritoneal metastases is becoming ever more significant for both palliative and curative cancer treatment. In order to bring the greatest possible benefit to the patient, both careful pre¬operative selection and also standardized perioperative management are crucial.
The Koch Mechnikov Forum Workshop "Management of Peritoneal Surface Malignancy" aims to discuss evidence-based clinical decision-making in the management of primary and secondary peritonal cancer and will offer a multidisciplinary program combining both practical aspects and theoretical problems.
Technical and clinical approaches will be revisited and updated. Presentations will include the state of the art and latest advancements, videos with tips and tricks by the experts in the field, and case reports. The workshop ist limited to a small number of participants (first come—first serve).
Ideal advanced Course Candidate
• Senior resident (last two years of training)
• Experienced consultant surgeon
• Good in English or Russian written and spoken (simultaneous translation is provided)
• Interdisciplinary approach
• Plenary lectures, work shop
• Video discussions
• Case reports
Deadline for Application: 15 May 2017. Please send a mail to the secretary.
Secretary & Registration
Sandra Wegel | firstname.lastname@example.org
Tel. +49 30 450 522 214 | Fax +49 30 450 7 622 214
Chair: Beate Rau, Dept. of General, Visceral, Vascular, and Thoracic Surgery, Charite Campus Mitte, Berlin, DE
Co-Chair: Viktoriya Dvornichenko, Head of Regional Oncology Hospital Irkutsk; RU
Andreas Brandl, Dept. of General, Visceral, Vascular, and Thoracic Surgery, Charite Campus Mitte, Berlin,DE
Tom Cecil, Peritoneal malignancy institute, Basingstoke Hospital, Basingstoke, GB
Vadim Gushchin, Surgical Oncology at Mercy Medical Center in Baltimore, Maryland, U.S.
Christhardt Kohler, Asklepios Hospital, Gynaecology Clinic: Special Surgical and Oncological Gynaecology; Hamburg; DE
Yan Li, Department of Oncology, Zhongnan Hospital of Wuhan University, CN
Verena Muller, Dept. of General, Visceral, Vascular, and Thoracic Surgery, Charite Campus Mitte, Berlin, DE
Francois Quenet, Montpellier Cancer Institute - ICM, FR Horst-Gunter Rau, Visceral and thoracic surgery at the HELIOS Amper-Klinikum Dachau, DE
Rodion Rasulov, Chief of pancreatic and liver tumor department, Irkutsk Regional Oncology Hospital, Irkutsk, RU
Roman Zubkov, Chief of stomach tumor department, Irkutsk Regional Oncology Hospital, Irkutsk, RU
Aleksei Shelekhov, Deputy chief physician, Irkutsk Regional Oncology Hospital, Irkutsk, RU
Paul Sugarbaker, Director of Surgical Oncology, Cancer Institute at Washington Hospital Center, Washington DC, U.S
Kurt van der Speeten, Faculty of Medicine, University of Leuven, Leuven, BE
Sascha Treskatsch, Dept. of Anesthesiology & Critical Care Medicine, Charite Campus Mitte, Berlin, DE
Yutaka Yonemura, Shizuoka Cancer Center, JP
Participation fee: The participation fee is 700 EUR. It includes the registration to the 3-day-course and a social dinner.
Accreditation: Accreditation has been requested from the Accred-itation Council of Oncology in Europe (ACOE).
Course Accommodation: We have rederved several rooms for our participants (under the keyword CRS and HIPEC 2017) at Marriott. Irkutsk, http://www.courtyardirkutsk.ru/ at the special price until 15 May 2017.
Irkutsk Regional Cancer Center Event Plan for 2021
|30.06-03.07.2021 г.||IV Siberian oncohematological forum|
|09-12.08.2021 г.||Forum “International Baikal school of Japanese medicine”|
|17-18.09.2021 г.||International practical scientific conference “Modern technologies in radiotherapy”|